[1]
2025. Computational Design and Molecular Docking of Perimidine–Peptide Hybrids as Next-Generation Topoisomerase IIα Inhibitors. Pakistan Journal of Medical & Cardiological Review. 4, 4 (Oct. 2025), 814–822. DOI:https://doi.org/10.64105/sz2xqc34.